MTN Group Limited (JSE:MTN)

Revance Therapeutics Income Statement

Financials in millions ZAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	188,001	221,056	207,003	181,646	179,361
Other Revenue	585	324	39	-	99
Revenue	188,586	221,380	207,042	181,646	179,460
Revenue Growth (YoY)	-14.81%	6.93%	13.98%	1.22%	18.49%
Cost of Revenue	70,748	78,493	69,055	59,737	63,170
Gross Profit	117,838	142,887	137,987	121,909	116,290
Selling, General & Admin	24,335	27,249	25,005	22,550	21,318
Other Operating Expenses	11,660	14,992	12,892	11,967	9,246
Operating Expenses	74,577	85,839	74,094	70,273	68,384
Operating Income	43,261	57,048	63,893	51,636	47,906
Interest Expense	-18,350	-18,954	-14,313	-13,138	-15,363
Interest & Investment Income	2,417	3,055	2,042	1,198	1,493
Earnings From Equity Investments	4,735	3,581	3,369	2,054	1,142
Currency Exchange Gain (Loss)	-18,879	-23,170	-6,055	-2,551	-4,537
Other Non Operating Income (Expenses)	-4,591	-8,045	-6,359	-6,479	-5,067
EBT Excluding Unusual Items	8,593	13,515	42,577	32,720	25,574
Impairment of Goodwill	-437	-	-625	-583	-998
Gain (Loss) on Sale of Investments	-	-	-	1,738	6,062
Gain (Loss) on Sale of Assets	-799	-900	-892	-4,720	-1,510
Asset Writedown	-11,774	-847	-170	-339	-42
Pretax Income	-4,417	11,768	40,890	28,816	29,086
Income Tax Expense	6,790	7,751	17,036	11,822	9,439
Earnings From Continuing Operations	-11,207	4,017	23,854	16,994	19,647
Minority Interest in Earnings	1,615	75	-4,817	-3,244	-2,625
Net Income	-9,592	4,092	19,037	13,750	17,022
Net Income to Common	-9,592	4,092	19,037	13,750	17,022
Net Income Growth	-	-78.50%	38.45%	-19.22%	87.06%
Shares Outstanding (Basic)	1,807	1,806	1,805	1,802	1,799
Shares Outstanding (Diluted)	1,807	1,838	1,852	1,849	1,818
Shares Change (YoY)	-1.71%	-0.76%	0.16%	1.71%	-0.41%
EPS (Basic)	-5.31	2.27	10.55	7.63	9.46
EPS (Diluted)	-5.31	2.23	10.28	7.44	9.36
EPS Growth	-	-78.31%	38.17%	-20.51%	87.95%
Free Cash Flow	22,183	31,871	36,723	42,873	35,011
Free Cash Flow Per Share	12.28	17.34	19.83	23.18	19.26
Dividend Per Share	3.450	3.300	3.300	3.000	-
Dividend Growth	4.54%	-	10.00%	-	-
Gross Margin	62.48%	64.54%	66.65%	67.11%	64.80%
Operating Margin	22.94%	25.77%	30.86%	28.43%	26.70%
Profit Margin	-5.09%	1.85%	9.20%	7.57%	9.49%
Free Cash Flow Margin	11.76%	14.40%	17.74%	23.60%	19.51%
EBITDA	65,859	84,991	87,364	75,481	72,763
EBITDA Margin	34.92%	38.39%	42.20%	41.55%	40.54%
D&A For EBITDA	22,598	27,943	23,471	23,845	24,857
EBIT	43,261	57,048	63,893	51,636	47,906
EBIT Margin	22.94%	25.77%	30.86%	28.43%	26.70%
Effective Tax Rate	-	65.86%	41.66%	41.03%	32.45%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.